A Phase I/II Study of CLOLAR (Clofarabine, IND 73, 789) in Combination With Cytarabine in Pediatric Patients With Refractory/Relapsed Leukemia.
Phase of Trial: Phase I/II
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine; Methotrexate
- Indications Acute myeloid leukaemia; Leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Feb 2017 Status changed from active, no longer recruiting to completed.
- 30 Sep 2015 Study design has been changed from single group assignment to parallel group assignment as reported by ClinicalTrials.gov record.